Impact of bile duct obstruction on hepatic E. coli infection: Role of IL-10

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 291, Issue 1, 2006, Pages

  Jeyarajah, D Rohan ^a,b   Kielar, Mariusz L ^a   Saboorian, Hoosein ^a   Karimi, Prameela ^a   Frantz, Nicole ^a   Lu, Christopher Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b METHODIST DALLAS MEDICAL CENTER   (United States)

Author keywords

Biliary; Cholangitis; Escherichia coli; Liver

Indexed keywords

INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BILE DUCT LIGATION; BILE DUCT OBSTRUCTION; CONTROLLED STUDY; ENTEROBACTER INFECTION; LIVER NECROSIS; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; CHOLESTASIS; ESCHERICHIA COLI INFECTIONS; HEPATITIS; INTERLEUKIN-10; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SURVIVAL RATE;

EID: 33745787050     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00095.2004     Document Type: Article

References (24)

1. Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, Holland G, Thompson-Snipes L, Leach MW, and Rennick D. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98: 1010-1020, 1996.
2. Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, and Gores GJ. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther 308: 1191-1196, 2004.
3. Canbay A, Friedman S, and Gores GJ. Apoptosis: the nexus of liver injury and fibrosis. Hepatology 39: 273-278, 2004.
4. Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, Rydzewski R, Taniai M, and Gores GJ. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 112: 152-159, 2003.
5. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, and Gores GJ. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 123: 1323-1330, 2002.
6. Csendes A, Sepulveda A, Burdiles P, Braghetto I, Bastias J, Schutte H, Diaz JC, Yarmuch J, and Maluenda F. Common bile duct pressure in patients with common bile duct stones with or without acute suppurative cholangitis. Arch Surg 123: 697-699, 1988.
7. Furukawa Y, Becker G, Stinn JL, Shimizu K, Libby P, and Mitchell RN. Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol 155: 1929-1939, 1999.
8. Genovese F, Mancuso G, Cuzzola M, Biondo C, Beninati C, Delfino D, and Teti G. Role of IL-10 in a neonatal mouse listeriosis model. J Immunol 163: 2777-2782, 1999.
9. Jeyarajah DR. Biliary Infection: Cholecystitis and Cholangitis. Current Therapy of Infectious Disease (2nd ed.), edited by Rege RV. St. Louis, MO: Mosby, 2001, p. 157-160.
10. Jeyarajah DR, Kielar ML, Zhou XJ, Zhang Y, and Lu CY. Acute bile duct ligation ameliorates ischemic renal failure. Nephron Physiol 95: 28-35, 2003.
11. Leung N, Croatt AJ, Haggard JJ, Grande JP, and Nath KA. Acute cholestatic liver disease protects against glycerol-induced acute renal failure in the rat. Kidney Int 60: 1047-1057, 2001.
12. Leung N, Croatt AJ, and Nath KA. Heme Oxygenase-1 (HO-1) is induced in the kidney in the bile duct ligation model (BDL) of acute renal insufficiency (ari) and influences renal function (Abstract). J Am Soc Nephrol 10: 635A. 1999.
13. Maluenda F, Csendes A, Burdiles P, and Diaz J. Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis. Hepatogastroenterology 36: 132-135, 1989.
14. O'Garra A, Vieira PL, Vieira P, and Goldfeld AE. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 114: 1372-1378, 2004.
15. Oberholzer A, Oberholzer C, and Moldawer LL. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 30: S58-S63, 2002.
16. Plebani M, Panozzo MP, Basso D, De Paoli M, Biasin R, and Infantolino D. Cytokines and the progression of liver damage in experimental bile duct ligation. Clin Exp Pharmacol Physiol 26: 358-363, 1999.
17. Rege RV. Adverse effects of biliary obstruction: implications for treatment of patients with obstructive jaundice. AJR Am J Roentgenol 164: 287-293, 1995.
18. Riedemann NC, Guo RF, and Ward PA. Novel strategies for the treatment of sepsis. Nat Med 9: 517-524, 2003.
19. Riedemann NC, Guo RF, and Ward PA. The enigma of sepsis. J Clin Invest 112: 460-467, 2003.
20. Saito JM and Maher JJ. Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. Gastroenterology 118: 1157-1168, 2000.
21. Sewnath ME, Olszyna DP, Birjmohun R, Ten Kate FJ, Gouma DJ, and van der PT. IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol 166: 6323-6331, 2001.
22. Sewnath ME, van der PT, Ten Kate FJ, Van Noorden CJ, and Gouma DJ. Interleukin-1 receptor type I gene-deficient bile duct-ligated mice are partially protected against endotoxin. Hepatology 35: 149-158, 2002.
23. Sewnath ME, van der PT, Van Noorden CJ, Ten Kate FJ, and Gouma DJ. Endogenous interferon gamma protects against cholestatic liver injury in mice. Hepatology 36: 1466-1477, 2002.
24. Thompson J Jr. Broad spectrum penicillin as an adequate therapy for acute cholangitis. Surg Gynecol Obstet 171: 275-282, 1990.